Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2 vs 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancer
NCT04023292Phase 2Unknown
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jul 2019
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in breast cancer (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Percentage Change in Ki-67 Labelling Index at 4 weeks. Status: unknown.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04023292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04023292.